Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003232031 | SCV003930269 | uncertain significance | not provided | 2023-05-10 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in the last 35 amino acids being replaced with 50 different amino acids; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV005102465 | SCV005771610 | uncertain significance | Autosomal dominant nocturnal frontal lobe epilepsy | 2024-06-07 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the CHRNA2 gene (p.Tyr495Glufs*51). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 35 amino acid(s) of the CHRNA2 protein and extend the protein by 15 additional amino acid residues. This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CHRNA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2504570). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |